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ReviewGlossary
Enantioconvergent process: two substrate enantiomers of a racemate are
(simultaneously or step-wise) transformed via independent pathways through
retention and inversion of configuration, respectively, yielding a single
stereoisomeric product in 100% theoretical yield.
Enantioselectivity: preference for one enantiomer of a racemic chiral molecule
in a (bio)chemical reaction.
E value (enantiomeric ratio): value describing the enantioselectivity of a kinetic
resolution as the ratio of the reaction rate of substrate enantiomers. The latter
can be calculated from kcat and KM values of enantiomers or from data sets of
conversion (c) and enantiomeric excess of substrate (eeS) or product (eeP)
when two out of the three parameters are known.
Heterochiral: compounds possessing an opposite sense of chirality.
Homochiral: compounds possessing the same sense of chirality.
Inversion: stereochemical switch of absolute configuration of a chiral carbon
atom caused by SN2 reaction, hence substrate and product possess opposite
absolute configurations.
Kinetic resolution: separation of enantiomers in a chemical reaction owing to
different reaction rates of enantiomers. Enantiopure product and (non-reacted)
substrate each can be obtained in 50% theoretical yields.Owing to the more abundant occurrence of racemic
compounds compared to prochiral or meso forms, most
enantiomerically pure products are obtained via race-
mate resolution. This review summarizes (chemo)enzy-
matic enantioconvergent processes based on the use of
hydrolytic enzymes, which are able to invert a stereo-
center during catalysis that can overcome the 50%-yield
limitation of kinetic resolution. Recent developments are
presented in the fields of inverting or retaining sulfa-
tases, epoxide hydrolases and dehalogenases, which
allow the production of secondary alcohols or vicinal
diols at a 100% theoretical yield from a racemate via
enantioconvergent processes.
Single enantiomers from racemates
Enzymes are gaining increasing attention as catalysts in
the chemical and pharmaceutical industry [1–3], as they
are the key to novel [4], more selective and ‘greener’
processes [5]. In the context of stereoselective (see Glossa-
ry) transformations, the trend favors processes that pro-
duce a single product at 100% theoretical yield without
occurrence of an unwanted enantiomer, which has to be
regarded as economic ballast (Figure 1). In a classic ap-
proach, desymmetrization of prochiral or meso-compounds
(M) represents a potent strategy for achieving this [6,7].
However, most chiral products are obtained via racemate
resolution owing to the more abundant occurrence of chiral
compared to prochiral substrate molecules. In most cases,
the residual 50% of unwanted substrate (ent-A) possessing
the ‘wrong’ absolute configuration is not applicable for
further processing, which sets a low economic ceiling in
kinetic resolutions. This drawback can be overcome by
three different methods.
The first and most frequently applied technique is dy-
namic kinetic resolution [8–10], which is used for the
deracemization of chiral alcohols, amines, amino acids,
and carboxylic acids. These processes combine an (enzy-
matic) kinetic resolution with in situ racemization of sub-
strate enantiomers A and ent-A by a chemocatalyst or
biocatalyst. The second technique is stereoinversion
[11,12], in which one enantiomer (A) of a racemic mixture
is selectively converted into an achiral intermediate (I)
that is reconverted into the opposite enantiomer, ent-A.0167-7799     
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Open access under CC BY license.Multienzymatic [13], chemoenzymatic [9], and chemical
systems [14] have been developed. This review is focused
on the third technique, that is, an enantioconvergent pro-
cess that makes use of two different reactions, which
convert a pair of enantiomers, A and ent-A, via retention
and inversion of configuration, respectively, to yield a
single product enantiomer, B, with a 100% theoretical
yield. In recent years, enzymatic [15,16], chemoenzymatic
[17–19], and chemical processes [20] have been developed.
This review focuses on enzyme-based protocols, which can
be classified into four types (Figure 2).
Type-1
In a type-1 process, a single enzyme converts both sub-
strate enantiomers (A and ent-A) through opposite path-
ways, that is, via inversion and retention of configuration
to furnish B as the sole enantiomeric product via an
elegant single-enzyme one-pot protocol. The requirements
for the catalytic performance for such a (bio)catalyst are
challenging, as the enzyme must not show any enantio-
preference (by converting one enantiomer leaving the other
untouched); rather, it should transform both enantiomers
(A and ent-A) at comparable rates but through opposite
stereochemical pathways. Such a process has so far only
been realized for epoxide hydrolases [15,21–24].Retention: the absolute configuration of a chiral carbon atom is not altered
during catalysis, hence substrate and product possess the same absolute
configuration. Formal retention can also be obtained via subsequent double
inversion.
Stereoselective: stereoselectivity describes the predominant formation of a
stereoisomer in a chemical reaction: for instance, via retention or inversion of
configuration.
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Figure 1. Strategies for the generation of single enantiomers from racemates in 100% theoretical yield. (A) Desymmetrization of a prochiral or meso-compound M
producing B as sole product. (B) Kinetic resolution of a pair of enantiomers (A and ent-A) yielding B and nonreacted ent-A. (C) Dynamic resolution of a pair of enantiomers A
and ent-A furnishing B as the sole product. (D) Stereoinversion of enantiomer A via nonchiral intermediate I to yield its mirror-image counterpart ent-A as the sole product.
(E) Enantioconvergent transformation of enantiomers A and ent-A through opposite stereochemical pathways forming B as sole product.
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If a single enzyme possessing the above requirements is
not available, two proteins can be combined in a type-2
process. In this case, both enzymes must show opposite
enantiopreference and a matching complementary stereo-
selectivity in terms of inversion or retention. When both
enzymes show high enantioselectivity, they can act simul-
taneously on both substrate enantiomers (A and ent-A) in a
one-pot protocol. Type-2 reactions have so far been shown
for epoxide hydrolases [25–27] and alkyl sulfatases [16].
Type-3
If one enzyme out of a matching stereocomplementary pair
shows insufficient enantioselectivity, bi-enzymatic one-pot
two-step processes of type 3 may be designed. In this case,
the reaction is conducted to 50% conversion by an enan-
tioselective enzyme via retention or inversion, to affect
kinetic resolution yielding either a homochiral or hetero-
chiral product mixture (A + B or ent-A + B, respectively).
Then, in a second step, the remaining non-converted sub-
strate enantiomer (A or ent-A) is reacted with matching
opposite stereochemistry via retention or inversion of con-
figuration. Because the second step starts with a single
enantiomer A or ent-A (which was not converted in the
preceding kinetic resolution step), enantioselectivity is not
required. Examples of bi-enzymatic type-3 reactions are
known for alkyl sulfatases [16]. Alternatively, chemocata-
lytic methods may be used for the second (nonenantiose-
lective) step to furnish chemoenzymatic type 3 protocols.
So far, no one-pot protocol has been developed owing to the
incompatibility of the (harsh) reaction conditions of the
chemical with those of the enzymatic step. Owing to the
higher enantioselectivity of enzymes compared to chemical
catalysts in general, the first step is invariably catalyzed by
a protein, whereas the second step is mediated by a (none-
nantioselective but stereoselective) chemocatalyst. Type-
3a processes rely on an inverting enzyme and lead to
a homochiral mixture of substrate A and product B after
the first enzymatic step. Consequently, the remaining
substrate A must then be converted with retention ofconfiguration to furnish B as the sole product. This process
has so far been developed for inverting alkyl sulfatases
[16,17]. Owing to the more abundant occurrence of retain-
ing enzymes, such as lipases, esterases, and proteases,
several type-3b applications are known. In this case, the
first step comprises a stereoselective retaining enzymatic
reaction that leads to a heterochiral mixture of substrate
ent-A and product B. In the second step, the residual
substrate ent-A must be converted via an inverting chemi-
cal (or enzymatic) reaction to furnish B [16,28–31].
Type-4
In type-4 reactions, an inverting enzyme is processing one
substrate enantiomer, leading to a homochiral mixture of
substrate A and product B, both of which are subjected to a
subsequent chemical (substitution) reaction with inversion
of configuration to furnish product ent-C. This process is
favorable when both substrate A and product B have a
strong leaving group that can easily be replaced. In some
cases, a weak leaving group has to be converted into a
better one via an additional activation step. This process
has been verified for haloalkane dehalogenases [19].
This review illustrates the power of stereocomplemen-
tary hydrolases for the design of enantioconvergent bio-
processes. To date, most enzymes have been found to act
via retention of configuration; inverting hydrolases occur
more rarely and so far have only been identified within the
groups of sulfatases, epoxide hydrolases, and dehalo-
genases. Although glycosidases may act through retention
or inversion at the anomeric center of a carbohydrate
substrate, they are not covered in this study because they
solely act on diasteriomeric (rather than enantiomeric)
substrates, which leads to de-epimerization as opposed
to de-racemization [32].
Sulfatases
In addition to their application in the biodegradation of
sulfur-containing organic waste and their role in various
cellular functions [33], sulfatases have intensively been
studied for their application in the deracemization of469
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Figure 2. Classification of (chemo)enzymatic enantioconvergent processes. (A,B)
Single-step enantioconvergence via a one-enzyme (A) or two-enzyme (B) process.
(C,D) Two-step enantioconvergence via inversion/retention (C) or retention/
inversion (D). (E) Two-step enantioconvergence via inversion followed by
chemical reaction. A, ent-A = substrate enantiomers; B, ent-B = product
enantiomers; ent-C = final product enantiomer.
Review Trends in Biotechnology August 2013, Vol. 31, No. 8sec-alcohols [16,34,35]. They have been classified into three
groups according to their mechanism (Figure 3) [36].
Arylsulfatases are the best-studied group. These
enzymes contain the hydrate form of a formyl glycine
residue (derived via post-translational modification of ser-
ine or cysteine), which triggers a nucleophilic attack on
sulfur. This leads to a cleavage of the CO–S bond of the
sulfate ester [33], which in turn leads to retention of
configuration at the chiral carbon center. The second group
consists of Fe(II) a-ketoglutarate-dependent alkylsulfa-
tases that belong to the dioxygenase superfamily [37]. They
oxidatively convert prim-sulfate esters into the corre-
sponding aldehyde and inorganic sulfate, which results
in the destruction of a chiral center. The third group of
sulfatases is formed by the metallo b-lactamase-related
Zn2+-dependent alkylsulfatases. The active site of these
enzymes contains a binuclear Zn2+ cluster that activates a
water molecule, which triggers a nucleophilic attack on the
chiral carbon center. In contrast to aryl sulfatases, this
leads to a breakage of the C–OS bond, causing inversion of
configuration at the chiral carbon atom. Sulfatase activity
in various microorganisms on sec-alkyl sulfates proceeding
via inversion [35,38] and retention [39] has been found, but
members of both groups of sulfatases were only recently
recombinantly produced and characterized on a molecular
level [16,17]. The first structure of a group III sulfatase470(SdsA1 from Pseudomonas aeruginosa) was solved in 2006
[36]. This enzyme was found to be unsuitable for stereo-
selective sulfate ester hydrolysis because it strongly pre-
fers nonchiral prim- over sec-alkyl sulfates [17,40]. The
first highly selective inverting sec-alkyl sulfatase was
Pisa1 from Pseudomonas DSM 6611, the structure of which
has recently been elucidated [40]. The reaction rates for
Pisa1 were much higher than for biotransformations with
whole cells of this organism [38] and reached the critical
50% threshold for many substrates in kinetic resolution
experiments. Inversion of configuration was proven by
reactions with enantiopure substrates and, in addition,
by labeling studies, which showed exclusive incorporation
of 18O in the product alcohol using 18O-labeled buffer [17].
Detailed investigation of the substrate spectrum of Pisa1
[41] revealed excellent stereoselectivities and perfect 50%
conversions for various (v-1)-, (v-2)- and 1-alkyn-3-yl sul-
fates. Terminal allylic substrates showed lower enantios-
electivity in comparison to propargylic counterparts owing
to competing (nonenzymatic) autohydrolysis. Competing
autohydrolysis could be significantly reduced by addition of
water-soluble cosolvents such as dimethyl sulfoxide
(DMSO). In addition, benzylic sec-alkylsulfate esters,
which also showed severe autohydrolysis, could be stabi-
lized by the presence of electron-withdrawing groups on
the aromatic ring (M. Toesch et al., unpublished). A che-
moenzymatic deracemization protocol requiring medium
change (Figure 2, type 3a) using Pisa1 (in the first step) and
acidic hydrolysis ( p-toluenesulfonic acid, MTBE/H2O 98:2)
in the second step, could be developed (Table 1) [16]. This
protocol was successfully applied to 5-hexen-2-yl sulfate as
the key step in the total asymmetric synthesis of (R)-
lasiodiplodin methyl ether, a precursor of the anti-leuke-
mic agent lasiodiplodin [42]. An analogous one-pot two-
step protocol was developed for 2-octyl sulfate [41], but its
applicability was limited by the strongly acidic reaction
conditions. These drawbacks could be circumvented by the
discovery of retaining sec-alkyl sulfatase activity for P.
aeruginosa arylsulfatase (PAS) [16]. Because the enzyme
showed opposite enantiopreference compared with Pisa1,
both enzymes could be combined in three different types of
one-pot enantioconvergent processes of type 3: In the first
case, highly enantioselective inverting Pisa1 yielded a
homochiral mixture of formed alcohol and nonconverted
sulfate via kinetic resolution. The residual substrate was
hydrolyzed by PAS with retention of configuration
(Figure 2, type 3a). In cases in which PAS showed high
enantioselectivity but Pisa1 did not, both enzymes were
used in reverse order, that is, PAS was applied first,
leading to a heterochiral mixture. The remaining sulfate
was then converted by Pisa1 with inversion of configura-
tion (Figure 2, type 3b). When both enzymes were enan-
tioselective, an elegant one-step protocol could be
developed (Figure 2, type 2). Although a one-enzyme
one-pot process of type 1, as shown for epoxide hydrolases
[15,21], is theoretically possible (Figure 2, type 1), the
likelihood for its realization is low, as it would require a
single sulfatase acting via nucleophilic attack at S versus C
on both substrate enantiomers. Nucleophilic attack at S
versus C is a consequence of the enzyme mechanism, which
completely differs for both types of sulfatases.
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Figure 3. Stereochemical action of inverting and retaining hydrolytic enzymes. (A) Retaining and inverting sulfatases act via breakage of S–O and C–O bonds, respectively.
(B) Inverting and retaining epoxide hydrolases act through regio-complementary attack at substituted or non-substituted oxirane carbon atoms, respectively. (C) Inverting
and retaining haloacid dehalogenases act via single or double SN2-displacement of halide, respectively. (D) Inverting haloalkane dehalogenases act via SN2-displacement of
halide, whereas the mode of action of retaining haloalkane dehalogenases is unknown.
Review Trends in Biotechnology August 2013, Vol. 31, No. 8Processes based on sulfatases have a high potential for
large-scale applications, as substrate and product are eas-
ily separable by simple extraction owing to their different
polarity.
Epoxide hydrolases
Epoxide hydrolases have gained a lot of attention for their
ability to produce enantiopure vicinal diols and epoxides,
which are both important building blocks for the asymmet-
ric synthesis of bioactive compounds [43]. Most of these
enzymes belong to the a/b-hydrolase superfamily and act
via nucleophilic SN2 attack of an aspartate residue that
forms a transient covalent enzyme–substrate–ester inter-
mediate with the substrate [44]. In the second step, an
activated water molecule attacks the carbonyl moiety of
the ester–intermediate, thereby releasing the product diol.
Overall, this leads to inversion of configuration at the oxi-
rane carbon atom being attacked (Figure 3). By contrast,
few enzymes have been shown to act through a one-stepmechanism via a borderline SN2 mechanism. The SN2
mechanism involves a direct attack of an activated water
molecule at one of the epoxide carbon atoms, which is
supported by general acid catalysis at the oxirane O-atom
[45]. Because the structure and function of epoxide hydro-
lases has been reviewed [46] and the application of these
enzymes in organic synthesis was covered in [43], this
review focuses on recent advances in enzyme engineering
of epoxide hydrolases and their application in enantiocon-
vergent biotransformations.
Epoxide hydrolases are so far the only enzymes known
that are able to achieve a one-enzyme enantioconvergent
process (Figure 2, type 1). The reason is that epoxide hydro-
lases not only show enantioselectivity (by preferring one
substrate enantiomer over the other) but also show regios-
electivity with respect to which oxirane carbon atom is
attacked (Figure 3). With epoxide hydrolases, nucleophilic
attack is possible on two adjacent epoxide carbon atoms via
the same enzyme mechanism, which is not possible with471
Table 1. Deracemization reactions using sulfatases, epoxide hydrolases, and dehalogenasesa
Substrate Product R Inversion Retention Absolute
configuration product
Selectivityb Conversionc Process type Refs
Sulfatases
OSO3
-
R
OH
R
n-alkyl (C4-8)
(CH2)2-CH=CMe2
(CH2)2CH=CH2
(CH2)1,2Ph, c-C6H11
Pisa1 Acid catalysis (S) +++ +++ 3a [17,41]
OSO3
-
R
OH
R
n-alkyl (C4,5) Pisa1 Acid catalysis (S) +++ +++ 3a [16,41]
OSO3
-
R
OH
R
n-alkyl (C5-7) Pisa1 Acid catalysis (R) +++
d +++ 3a [41]
OSO3
-
R
OH
R
n-alkyl (C4,5)
CH2-CHMe2
Pisa1
Pisa1
PAS
Acid catalysis
(R)
(R)
+++
+++
+++
+++
3a [16,41]
OSO3
-
R
OH
R
Me, Et Pisa1 PAS (S) +++ +++ 3b [16]
OSO3
-
Ph
OH
Ph
– Pisa1
Pisa1
PAS
Acid catalysis
(S)
(S)
+++d
+++d
+++
+++
2
3a
[16,41]
OSO3
-
R
OH
R
m-CF3,
m,m-(CF3)2
Pisa1
Pisa1
PAS
Acid catalysis
(S)
(S)
+++e
+++e
++
+++
2
KR
[16,41]
Epoxide hydrolases
O
R R
OHOH H, m-, p-Cl CcEHase
BsEHase
CcEHase
AnEHase
(R)
(R)
++
++
+++
+++
1
2
[24,43]
[27,43]
R
O
R
OH OH n-C5H11, Ph, (CH2)3CH=CH2,
(CH2)4Br, CH2OBn
Acid catalysis Retaining EHase (S) +++ +++ 3b [43,97]
R1
O
R2rac-c is R1 R2
OH OH R
1: n-alkyl (C1,2,4,8)
Cl-CH2, HO-(CH2)2,10,
(CH2)7CO2H, CH2CH=CH(CH2)7CO2H
R2: n-alkyl (C3-5,7,10),
(CH2)7CO2H, (CH2)10OH,
CH2CH=CH-C5H11
Inverting EHase n.a. (R,R) ++ +++ 1 [43]
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Haloacid dehalogenases
Cl
O
OH
OH
O
OH
– L-a-HADH (P. putida) Base catalysis (R) ++ n.d. 3af [78,79]
Haloalkane dehalogenases
R
Br
R
OH n-alkyl (C3,4) DatA
DbjA
n.a. n.d.
(S)
+++
++
+++
+++
KR [85]
[86,87]
Br
O
O
R
OH
O
O
R
Me, Et DatA
DbjA
DhaA
LinB
n.a. n.d.
(S)
n.d.
n.d.
+++
+++
+++
+
+++
+++
+++
+++
KR [85]
[86,87]
[86]
[86]
Br
O
O
R
OH
O
O
R
Me, Et Dbja
DhaA
DpcA
LinB
n.a. (S)
n.d.
(S)
n.d.
+++
+++
+++
+++
+++
+++
n.d.
+++
KR [86,87]
[86]
[98]
[86]
Br
H
N
O
R
Nu
H
N
O
R
Ph, Bn,
CH2CO2t-Bu
DbjA
DhaA
DhA31
Nu (S)
(S)
(S)
+++
+++
+++
+++

+++
4
KR
KR
[19,93]
[93]
[93]
Br
H
N
O
R
Nu
H
N
O
R
Bn LinB Nu (S) +++ + 4 [19,93]
R1: CH2CO2t-Bu
R2: Me, Bn
LinB n.a. (S,S)g +++ +++ 4 [93]
Cl
Cl Cl
Cl
Cl OH
– R5-90R
R5-97S
n.a. (R)
(S)
++
+++
n.d.
n.d.
DS [91]
aAbbreviations: An., Aspergillus niger; Bn, benzyl = CH2Ph; Bs, Bacillus subtilis; Bu, butyl; Cc, Caulobacter crescentus; DS, desymmetrization of prochiral substrate; EHase, epoxide hydrolase; Et, ethyl; HADH, haloacid dehalogenase;
KR, kinetic resolution; PAS, P. aeruginosa arylsulfatase; Ph, phenyl; n.a., not applicable; n.d., not determined; Nu, nucleophile.
bEnantioselectivity of kinetic resolution with inverting enzyme: +++, E > 200; ++, 200 > E > 100; +, 100 > E > 50;, 50 > E > 25; –, E < 25. Enantiomeric excess of product from enantioconvergent process: +++,>97%; ++, 97–90%; + 90–
80%; , 80–60%; – <60%.
cConversion in kinetic resolution with inverting enzyme: +++, >45%; ++, 45–40%; +, 40–30%; , 30–15%; –, <15%. Overall conversions of enantioconvergent process: +++, >90%; ++, 90–80%; +, 80–60%; , 60–30%; –, <30%.
dCompeting autohydrolysis was suppressed by addition of 20% DMSO (v/v).
eHigh selectivity only in presence of electron withdrawing groups (R) on the aromatic ring.
fDescribed as enantioconvergent process, which seems to be impossible under the reaction conditions chosen.
gOwing to the presence of a second chiral center, a diastereomeric product is obtained.
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Review Trends in Biotechnology August 2013, Vol. 31, No. 8stereocomplementary sec-alkylsulfatases. Nevertheless, on-
ly few enantioconvergent processes using overexpressed
epoxide hydrolases have been reported with high stereose-
lectivity and conversion (Table 1). Eight racemic styrene
oxide derivatives have been tested with lyophilized whole
cells of an overexpressed epoxide hydrolase from Caulobac-
ter crescentus [21]. Best results were obtained for p-chlor-
ostyrene oxide yielding the corresponding (R)-diol with 95%
enantiomeric excess (ee) and 72% yield in a preparative-
scale experiment. Metagenomic studies also proved to be a
valuable source for novel epoxide hydrolases. The epoxide
hydrolase Kau2 derived from biofilter DNA was able to
convert racemic cis-1-phenyl-1,2-epoxypropane to its corre-
sponding (1R,2R)-diol with 97% yield and >98% ee [47]. An
epoxide hydrolase from Aspergillus niger was evolved by
iterative combinatorial active-site saturation test (CAST),
leading to significantly increased stereoselectivity (enantio-
meric ratio E from 4.6 to 115) for glycidyl phenyl ether [48].
Every evolutionary step was analyzed by molecular dynam-
ic simulations and molecular modeling, which provided
insights into the enzymatic mechanism. The same enzyme
was further engineered for the enantioconvergent hydroly-
sis of 2,3-disubstituted epoxides [49]. Several mutants
yielded the corresponding vic-diol in 99% ee and >90%
conversions. The same group was also able to broaden the
substrate spectrum of limonene epoxide hydrolase from
Rhodococcus erythropolis DCL 14 via iterative site directed
mutagenesis (ISM) [50]. ISM was also used to alter the
enantiopreference of potato epoxide hydrolase StEH1 for
(2,3-epoxypropyl)benzene [51]. Further studies resulted in
mutants with altered regio- and enantioselectivity [52].
Enantioselectivity enhancement by single-point mutation
could be achieved in the substrate access tunnel of A. niger
M200 epoxide hydrolase [53] and in the active site of Agro-
bacterium radiobacter epoxide hydrolase [54].
One-pot processes with two enantiocomplementary ep-
oxide hydrolases (Figure 2, type 2) have recently been
developed for the production of (R)-phenyl-1,2-ethanediol
using enzyme pairs from A. niger LK/Rhodotorula glutinis
[25] and C. crescentus/Mugil cephalus [26] with >90% ee and
conversion. High selectivity and conversion were also
obtained when two enzymes from the Neocarzinostatin gene
cluster were combined in a biocatalytic deracemization
protocol [55]. The main issue to solve is the evolution of
epoxide hydrolases towards a broader substrate spectrum
and enhanced stereoselectivities, next to improved activities
and stability towards increased substrate concentrations.
Dehalogenases
Dehalogenases are highly attractive enzymes for industry
because they can be used not only for the bioremediation of
recalcitrant halo-organic compounds [56] but also as cat-
alysts for the synthesis of enantiopure building blocks [57].
This review focuses on the synthesis of enantiopure build-
ing blocks and covers recent advances and novel processes
involving haloacid and haloalkane dehalogenases.
Haloacid dehalogenases
Haloacid dehalogenases catalyze the hydrolytic dehalo-
genation of a-haloalkanoic acids to the corresponding
a-hydroxyalkanoic acids (Figure 3) [58]. They have been474classified either according to their sequence [59] or based
on their stereoselectivity [60,61]; in this review the latter
classification is used.
The best-studied group are L-2-haloacid dehalogenases
that convert (S)-2-haloalkanoic acids into (R)-2-hydro-
xyalkanoic acids with inversion of configuration (Table
1). Several of their structures have already been solved
and characterized [62–66]. The mechanism proceeds via
nucleophilic attack of an aspartate moiety on the chiral
carbon center bearing the halogen, leading to a covalent
enzyme–substrate–ester intermediate, which has a strong
resemblance to that of SN2-type epoxide hydrolases. The
ester-intermediate is then attacked by an activated water
molecule, thereby triggering the product release. This
mechanism has been supported by 18O-labeling experi-
ments for the haloacid dehalogenase of Pseudomonas sp.
YL [67]. Product labeling was found in multi- but not in
single-turnover experiments, which suggests that the oxy-
gen atom derived from water is incorporated into the
nucleophilic Asp moiety via H2O attack on the enzyme–
substrate–ester intermediate. The importance of this resi-
due for catalysis was further strengthened by site directed
mutagenesis [63,68].
The second group are inverting DL-2-haloacid dehalo-
genases, which have been covered in a recent review [69].
They can convert both substrate enantiomers, which is
quite unusual for enzymatic reactions and is only typical
for the group of racemases [70]. Their reaction mechanism
differs from L-2-haloacid dehalogenases such that it does
not involve the formation of a covalent enzyme–substrate–
ester intermediate, but proceeds through direct nucleophil-
ic attack of an activated water molecule at the chiral
carbon center. In this respect, it shows strong similarities
with borderline-SN2-epoxide hydrolases.
18O-labeling
studies showed that incorporation of 18O took place in both
single- and multi-turnover reactions and no 18O-labeled
enzyme fragments were found [71]. Detailed mechanistic
studies on the structure of DheI from Pseudomonas putida
PP3 [66] revealed that Asp189 was responsible for water
activation, which is assisted by an adjacent Asn114 resi-
due. Remarkably, DL-2-haloacid dehalogenase DL-DEX
312 from P. putida PP3 also acted on 2-chloro- and 2-
bromopropionamide [72].
The third group of a-haloacid dehalogenases are invert-
ing D-2-haloacid dehalogenases, which have the same cat-
alytic mechanism (with high sequence similarity) as DL-2-
haloacid dehalogenases but specifically act on the (R)-
enantiomer of a-haloacids. Although their mechanism
has been investigated [73], no crystal structure is yet
available. Recently, structure prediction, molecular dy-
namics simulation and substrate docking were conducted
for DheI from Rhizobium sp. RC1 to elucidate the catalytic
residues [74]. Recently, literature on D-specific haloacid
dehalogenases has been summarized [75].
The fourth group of a-haloacid dehalogenases are
retaining DL-2-haloacid dehalogenases. So far, only one
enzyme from P. putida PP3 was found to display this
activity [76]. A mechanism involving double inversion of
configuration was proposed but has not been proven,
which is further complicated by the lack of sequence
information.
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a-haloacid dehalogenases were conducted with rac-a-chlor-
opropionic acid (rac-CPA), the (S)-enantiomer of which was
selectively hydrolyzed to (R)-lactic acid by an L-selective
dehalogenase (Table 1). The residual non-converted mir-
ror-image (R)-enantiomer was separated and was converted
into (S)-lactate with a DL-2-haloacid dehalogenase, which
overall constitutes kinetic resolution [77]. An industrial
application of kinetic resolution of rac-CPA by an inverting
(R)-haloacid dehalogenase was developed by AstraZeneca,
leading to enantiopure (S)-CPA in >90% conversion. [78].
This process was also adapted to several other chiral short-
chain a-haloacids and was shown to be suitable for a scale-
up to >1000 t per annum. A chemoenzymatic enantiocon-
vergent process (Figure 2, type 3a) for the production of (R)-
lactic acid in 94% ee was claimed by combining an enantio-
selective inverting L-2-haloacid dehalogenase with base-
catalyzed (chemical) hydrolysis of the residual substrate
enantiomer with retention of configuration [79]. However,
the latter step is known to proceed with SN2 inversion of
configuration, which raises some doubts on the feasibility of
this process. Furthermore, it has been stated [78] that CPA
tends to racemize under basic conditions; this is likely to
account for the high conversion beyond 50% in the first
(enzymatic) step, which renders a dynamic resolution (rath-
er than an enantioconvergent process), thereby making the
second (chemical) step dispensable. In addition, the appli-
cability of this process would be limited because it requires
several separation steps in downstream processing owing to
the incompatibility of the enzymatic step with the increased
reaction temperatures and extreme pH required for the
chemical hydrolysis. The ability of an L-2-haloacid dehalo-
genase to act in organic solvents [80] enabled the extension
of the substrate spectrum to a-haloacids bearing lipophilic
aromatic (phenyl and benzyl) and long alkyl (C5–C16) side
chains.
The application of a-haloacid dehalogenases in derace-
mization processes has so far been limited to the produc-
tion of enantiopure (R)-lactic acid using inverting enzymes,
even though studies in the 1980s and 1990s indicated a
much wider potential. The molecular characterization of
an a-haloacid dehalogenase with retaining stereocomple-
mentary would be a huge step towards the development of
type 2 or 3 enantioconvergent processes for the production
of enantiopure a-hydroxyacids from the corresponding
easily accessible rac-a-haloacids. If more enzymes could
be shown to be compatible with organic solvents, such as a-
haloacid dehalogenase from P. putida [80], access to a
wider substrate range would be opened.
Haloalkane dehalogenases
In contrast to a-haloacid dehalogenases, which nucleophil-
ically displace electronically activated halogen atoms,
haloalkane dehalogenases produce alcohols from non-acti-
vated organohalogen compounds (Figure 2). This unique
ability is the reason for their high potential in several areas
of biotechnology, such as biocatalysis, by-product recycling,
bioremediation, biosensing, cell imaging, and protein anal-
ysis, which were recently covered in a review [81]. Here, we
delve into their potential and application in biocatalytic
deracemization processes.Haloalkane dehalogenases belong to the a/b-hydrolase
superfamily. They hydrolytically convert halo-aliphatic
substrates via a nucleophilic SN2-substitution into the
corresponding alcohols with inversion of configuration at
the chiral carbon center. Unlike the mechanistically relat-
ed fluoroacetate and L-a-haloacid dehalogenases, they are
not able to cleave carbon-fluorine bonds [82]. Their active
site is located in a hydrophobic cavity between the a/b-
hydrolase core and a variable cap domain. Access to the
active site is regulated by a tunnel. The active site consists
of a catalytic pentad with three key residues that are
conserved amongst all enzymes – Asp acting as a nucleo-
phile, His activating a water molecule, and Trp for halide
leaving group stabilization. Haloalkane dehalogenases
have been divided into three phylogenetic groups on the
basis of sequence and structural data [83]. A more recent
classification based on their substrate spectrum divides
them into four substrate-specificity groups [84]. Besides
mechanistic aspects, the enantioselectivity of haloalkane
dehalogenases is of great importance, because the stereo-
selective nucleophilic displacement of a halide by [OH]
has no counterpart in traditional chemical methodology.
An overview of highly selective enzymatic dehalogenation
reactions is given in Table 1.
For simple n-2-haloalkanes, the selectivity is highest for
2-bromopentane and 2-bromohexane (DatA from Agrobac-
terium tumefaciens: E > 200 [85]) but decreases signifi-
cantly (E < 30 for all tested enzymes) with increasing and
decreasing chain length. By contrast, improved enantios-
electivities were found on a-haloesters. This phenomenon
was studied in more detail for DbjA from Bradyrhizobium
japonicum USDA 110 using 2-bromopentane and methyl 2-
bromobutyrate as substrates [86], which revealed different
binding modes for the two substrate types. The stronger
enantiomer discrimination for methyl 2-bromobutyrate is
due to additional hydrogen bonding of its carbonyl group.
Furthermore, it was shown that selectivity changes for
both substrates were unrelated to each other when muta-
tions in the surface loop area were performed [87]. Al-
though pH changes led to a change in the oligomeric state
of the enzyme, neither the secondary and tertiary structure
nor the enantioselectivity was altered. By contrast, a
temperature increase from 208C to 508C led to a signifi-
cantly reduced E value (E from 174 to 13 for 2-bromopen-
tane, E from 474 to 197 for ethyl 2-bromopropionate, and E
from 225 to 83 for methyl 2-bromobutyrate). In a recent
study, the thermostability and resistance to organic co-
solvents of DhaA from Rhodococcus rhodochrous
NCIMB13064 could be drastically improved, as proven
by an increase of melting temperature TM up to 198C
and an extended half-life in 40% DMSO from minutes to
several weeks [88]. Modification of the substrate tunnels
proved to be a potent tool for obtaining highly improved
dehalogenase variants. For instance, the catalytic activity
on the toxic anthropogenic compound 1,2,3-trichloropro-
pane (TCP) could be enhanced 32-fold and the efficiency by
26-fold [89]. In addition, the most active mutant, DhaA31
(which showed high activity but poor stereoselectivity),
was further evolved towards the stereoselective conversion
of TCP into (R)- or (S)-2,3-dichloropropan-1-ol, which can
be chemically processed into enantiopure epichlorohydrin475
Box 1. Outstanding challenges
 The search for retaining sulfatases that possess a broad substrate
spectrum.
 The verification of retaining haloacid dehalogenases.
 The identification of retaining haloalkane dehalogenases.
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their chiral center [90,91]. Carefully designed mutants
giving (R)-2,3-dichloropropan-1-ol in 90% ee and the (S)-
enantiomer in 97% ee could be obtained from a screening of
only 5500 variants after five rounds of evolution. Recently,
a one-enzyme tandem-desymmetrization/kinetic resolu-
tion process of short-chain prochiral and meso-dihaloalk-
anes was shown [92]. In this protocol, the dihaloalkane was
converted to the haloalcohol in a first step, which was
further dehalogenated to the corresponding diol. A highly
enantioenriched haloalcohol was obtained when the
slower-produced haloalcohol enantiomer was processed
faster to the diol. By this means, the ee of (R)-3-bromo-
2-methylpropan-1-ol could be pushed to 97% (24% conver-
sion) and that of (S)-3-bromo-2-phenylpropan-1-ol (52%
conversion) to 98%. Haloalkane dehalogenases were also
applied to the preparation of a-hydroxyamides via dera-
cemization. Fourteen a-bromoamides were subjected to
kinetic resolution with five heterologously expressed
haloalkane dehalogenases [93], and E values of >200 were
achieved for several a-haloamides. Furthermore, molecu-
lar dynamic simulations with LinB–substrate complexes
showed that the preferred (R)-enantiomer was more favor-
ably bound in the active site. A dynamic kinetic resolution
(DKR) procedure using polymer-based phosphonium bro-
mide as the racemization catalyst led to highly enantioen-
riched a-hydroxyamides [94]. The reactions had to be
conducted in a membrane reaction system to avoid inacti-
vation of the enzyme by the racemizing polymer. The proto-
col is of high interest because it presents a DKR procedure
that is not dependent on environmentally questionable
heavy metal complexes. The first enantioconvergent process
(Figure 2, type 4) based on haloalkane dehalogenases was
recently developed for the chemoenzymatic synthesis of a-
substituted amides, which are key intermediates in the
production of pharmacologically active compounds [19]. In
the first enzymatic kinetic resolution step, a homochiral
mixture of a-bromo- and a-hydroxyamide was obtained
using an inverting dehalogenase. In the second step, the
formed a-hydroxyamide was chemically activated by a
methylsulfonyl leaving group, which was subsequently dis-
placed in situ by N, O and S nucleophiles, leading to highly
enantioenriched a-substituted amides with excellent yields
and selectivity. In summary, haloalkane dehalogenases
possess a largely underestimated potential for the chemical
industry, as they are able to not only degenerate toxic
xenobiotic organohalogen compounds [95,96] but also selec-
tively convert them into useful chiral building blocks. For
such transformations, counterparts in traditional chemical
methodology occur rarely.
Concluding remarks
Hydrolytic enzymes, such as sulfatases, epoxide hydro-
lases, and dehalogenases, possess the rare feature to act
through different mechanisms affecting retention or inver-
sion of configuration of a chiral carbon atom. Therefore,
they represent crucial tools for the development of dera-
cemization techniques, which allow the conversion of a
racemic substrate mixture to a single enantiomeric product
via independent enantioconvergent pathways with a 100%
theoretical yield. To date, several successful applications476have been shown for alkyl sulfatases, epoxide hydrolases,
and dehalogenases. The crucial challenge for future devel-
opments is the extension of the number of inverting hydro-
lases, which may be achieved by the identification of novel
enzymes from unexpected biodegradation pathways or by
the re-engineering of the catalytic mechanism of well-
known retaining hydrolases (Box 1).
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